This inventor holds 26 USPTO granted patents and 16 published patent applications and 5 EPO patents, primarily in Immunomodulation and Cancer Therapy. Top assignees: Rubius Therapeutics, Inc., Flagship Pioneering Innovations V, Inc., Editas Medicine, Inc.. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Happy Valley, OR (US) (2021)
- Somerville, MA (US) (2017 - 2023)
- Baltimore, MD (US) (2019 - 2023)
Company Filing History:
15 out of 16 
7 out of 36 
4 out of 54 
Years Active: 2017-2023
Areas of Expertise:
Title: The Innovative Journey of Jordi Mata-Fink
Introduction: Jordi Mata-Fink is an accomplished inventor based in Somerville, MA, known for his significant contributions to the field of immunology. With 26 patents to his name, he has made considerable strides in developing methods and compositions aimed at immunomodulation, showcasing his dedication to advancing medical science.
Latest Patents: Among his latest innovations, Jordi has worked on groundbreaking patents titled "Methods and compositions for immunomodulation - Provided are cells containing exogenous antigen and uses thereof." These patents represent a vital step forward in exploring how specific cells can be utilized to modulate immune responses, potentially leading to improved therapeutic applications.
Career Highlights: Jordi Mata-Fink's career features prominent roles at notable companies such as Rubius Therapeutics, Inc. and Flagship Pioneering Innovations V, Inc. His expertise in the biotech sector has paved the way for advancements in immunomodulatory strategies, emphasizing his role as a leading figure in this area of research.
Collaborations: Throughout his career, Jordi has collaborated with esteemed colleagues including Avak Kahvejian and John Round. These partnerships reflect his commitment to teamwork and innovation, fostering an environment where groundbreaking ideas can thrive.
Conclusion: Jordi Mata-Fink stands out as a significant inventor in the realm of immunology. His extensive patent portfolio and collaborative efforts underscore his impact on the industry. With a focus on advancing immunomodulation techniques, he continues to contribute to meaningful innovations that may improve healthcare outcomes for many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile